The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies.
Related Posts
CMS finalizes rule cracking down on Medicaid provider taxes
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The CMS on Thursday finalized […]
Key readings to help you evaluate a major change to US drug pricing policy – Healthcare Economist
That is the topic from my article out today at The Evidence Base. An excerpt is below: On May 12, […]
Sectra Acquires Oxipit to Scale Autonomous Diagnostic Imaging
What You Should Know The Deal: Swedish medical imaging and cybersecurity giant Sectra has entered into an agreement to acquire Oxipit, a Lithuanian startup specializing […]